Type
. [Increase in nitric oxide concentrations in serum and mononuclear cell cultures from patients with Type II reaction state of Hansen's disease]. Investigacion clinica. 2003;44(2):129-36.
Type
. Mast cell subsets and neuropeptides in leprosy reactions. Arquivos de neuro-psiquiatria. 2003;61(2A):208-19.
Type
. [Concept of WHO for leprosy therapy]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2003;72(1):1-2.
Type
. Histoid leprosy: diagnosis by fine needle aspiration cytology. Acta cytologica. 2003;47(3):529-31.
Type
. Systemic dissemination in tuberculosis and leprosy: do mycobacterial adhesins play a role?. Microbes and infection. 2003;5(7):677-84.
Type
. Geographically specific infections and arthritis, including rheumatic syndromes associated with certain fungi and parasites, Brucella species and Mycobacterium leprae. Best practice & research. Clinical rheumatology. 2003;17(2):289-307.
Type
. Dentistry in the Amazon. The Alpha omegan. 2003;96(1):32-4.
Type
. Chronic macrocheilia: a clinico-pathological study of 28 patients. Clinical and experimental dermatology. 2003;28(3):245-50.
Type
. Saints protectors from leprosy: historical hints of suggestive therapy?. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2002;70(4):269-73. Available from: http://ila.ilsl.br/pdfs/v70n4a04.pdf
Type
. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2002;70(4):245-9. Available from: http://ila.ilsl.br/pdfs/v70n4a01.pdf